富士胶片:推进内窥镜检查以检测和战胜结直肠癌

测试与扫描
英雄符号

作者:Tai Fujita

藤田泰 是FUJIFILM Healthcare Americas的内窥镜业务总经理。 他毕业于东京庆应大学,这是日本最古老的西方高等教育机构。.

Robert, a father of two, husband and salesman who travels around the world for work, started experiencing abdominal pain and found himself feeling more tired than usual. At first, he chalked these symptoms up to a busy work schedule and diet changes due to business travel but decided to see his doctor for a checkup to be safe.

After talking through his symptoms, Robert and his physician agreed that a colonoscopy was required to get to the root of the problem.

During the colonoscopy, Robert’s physician found and was able to completely remove several 瘜肉, some of which were pre-cancerous.

Fortunately, because Robert’s cancer was found in its early stages, he was able to undergo a successful surgery. Today, Robert is cancer free and lives a fruitful life doing the things he loves: spending time with his family and working in a rewarding career.

Individuals like Robert are embracing life today for one simple reason: Colonoscopy. Thanks to this non–invasive screening exam, Robert’s doctors caught colorectal cancer soon enough to save his life.

儿童权利委员会:可治疗和可战胜

Colorectal cancer (CRC) is the third most common cancer in men and women in the United States and the second most deadly behind lung cancer. In 2024 CRC moved up from the fourth to the third most common cancer, and of all cancers, CRC is expected to take the most lives of people under 50 by 2030.

The U.S. Preventive Services Task force strongly believes that regular screenings are the best way to keep this cancer at bay, leading to their decision in 2021 to lower the age for CRC screenings to 45 after a worrisome spike in cases of CRC in people younger than 50.

While the statistics are unsettling, medical device innovators are continuously bringing new and advanced endoscopy solutions for use in hospitals and ambulatory surgery centers (ASCs) across the country. This is crucial as screening with endoscopes can find pre-cancerous polyps so they can be removed before they turn into cancer. They can also detect CRC early when treatment works best.

这意味着,通过适当的筛查,儿童早期癌症可以成为最可预防、可治疗和可战胜的疾病之一。

前面是关于内部观察

让我们面对它吧。结肠镜检查的话题会让一些人感到焦虑、尴尬,甚至害怕。值得庆幸的是,许多组织和名人已经采取措施,减少围绕结肠镜检查的任何潜在担忧。

Singer/songwriter Sheryl Crow, actor Ryan Reynolds, racecar driver Scott Lagasse, Jr., professional quarterback Dak Prescott, and Texas Rangers third-base coach Tony Beasley have all been involved in initiatives to raise awareness about the importance of screenings. Indeed, celebrities are very much out front about looking inside!

After all, that’s exactly what a 结肠镜检查, which is performed with an endoscope, does. The Greek prefix “endo-” means "within, inside." With endoscopes, physicians can look inside the body to detect, diagnose, and treat diseases in minimally-or non-invasive ways—so conditions that once required surgery can now be addressed without even making an incision.

However, while screening modalities can effectively reduce CRC incidence, U.S. screening rates remain low at 67%.

It isn’t surprising, then, that coincident with the decrease in endoscopic procedures, there was a concerning increase in early-onset colorectal cancer. That’s why now it’s more important than ever for all stakeholders—doctors, patient advocacy groups and medical device companies—to encourage patients to get back on track with their routine screenings.

This is why Fujifilm has partnered with Fight CRC.

Moreover, Fujifilm’s innovations support both the screening and treatment of CRC worldwide to help to tackle the surge of early-onset colorectal cancer.

下一代技术

Staying true to our photography and imaging roots, one of Fujifilm’s most impactful solutions available today uses high-definition imaging to give physicians a greater look at what’s happening inside the body – now with the help of Artificial Intelligence (AI).

New advancements in AI help alert patient’s physicians of polyps in real-time – both visually and audibly – even those that can be hard for the human eye to see. Studies show that Fujifilm’s newest AI technology for endoscopy – known as CAD EYE - is supporting physicians by helping to identify polyps during colonoscopy procedures in real-time.

Also in 2024, Fujifilm introduced SCALE EYE, a new and innovative endoscopic imaging technology for measuring colonic polyps. A patient’s polyp size is important, as the size helps the endoscopists determine how often a patient should return for follow-up screening or how they should remove the polyps.

While the industry has had access to a few tools like physical endoscopic rulers to help measure polyps once they are removed, they are cumbersome to use and time-consuming. Early results of Fujifilm’s SCALE EYE technology – a virtual measuring tool visible through the endoscope at the touch of a button - show it is superior in terms of accuracy and time compared with other traditional methods.

该图像显示了利用白光成像、联动彩色成像(LCI)、蓝光成像(BLI)和放大的BLI来支持结肠息肉的检测和光学诊断的比较。

(A) 白光成像。(B)LCI提高了肿瘤的可探测性;(C)BLI提高了肿瘤的可探测性;(D)放大的BLI显示了扩张的隐窝和扩张的血管。非息肉状病变,10毫米,盲肠。高等级腺瘤

推进护理和教育

Fujifilm is advancing patient care and physician education at hundreds of clinical settings across the U.S., from leading academic medical centers to small ambulatory surgery centers (ASCs). For example, fully integrated Fujifilm endoscopy systems have been installed at Dartmouth, in Colorado at PEAK内窥镜检查此外,还有佛罗里达大学、纽约大学、俄亥俄州的胃病集团、弗吉尼亚州的VCU健康中心、华盛顿州的普罗维登斯圣约瑟夫医院以及杰克逊维尔的梅奥诊所等等。

最令人兴奋的装置之一是在 布里格姆和妇女医院 in Massachusetts which has been Fujifilm’s long-term endoscopy research partner and collaborator and is consistently ranked in the top tier of hospitals in the nation.

In 2022, 配备了富士胶片 the 15,000-member American Society for Gastrointestinal Endoscopy (ASGE) Institute for Training & Technology, and global leader of advancement and education in the field of GI endoscopy, with 16 of Fujifilm’s industry-leading ELUXEO Endoscopic Imaging Systems and twenty 700 Series Endoscopes. The suite of comprehensive endoscopy solutions was installed in August 2022 and is utilized throughout ASGE’s live and virtual training programs for both endoscopy fellows and seasoned endoscopy professionals.

更重要的是,富士胶片与世界各地众多著名医疗机构的顶尖医生建立了战略伙伴关系。这些著名的医生提供意见,帮助我们优化现有的技术,并促进下一代先进技术的发展,以延长和拯救生命。

Innovation and collaboration fuels Fujifilm and our partners. Our collective mission is to raise awareness, boost screening compliance, and improve colorectal cancer patient outcomes. Talk to your doctor about colonoscopy screening today. It could save your life tomorrow.

为大局而转变

许多人知道富士胶片的即拍即得["INSTAX"]和数码相机,但你知道吗,该公司在1936年开始将其专业知识应用于成像保健,从其照片胶片中开发出X射线胶片。

从那时起,富士胶片一直在改造其从生产照片胶片发展起来的核心技术,并将其大部分精力投入到医药、生物技术和保健方面。

该公司的企业和使命的重塑是如此不同寻常,它成为哈佛商业案例研究的经典,也是最近《财富》杂志的专题报道。

我们的数码相机是用X-Trans CMOS传感器开发的,以产生高质量的图像,具有捕捉大画面所需的丰富色彩、色调和尺寸。现在想象一下,调整和改造这种成像技术,以实现可视化你的消化道中最小的微血管所需的细节和精度。这就是创新。

今天,富士胶片的医学影像创新是这种转变的关键因素,并在全球各地的一线医疗机构中得到应用。我们强大的医学影像组合包括数字放射摄影、乳腺摄影、计算机断层扫描、核磁共振、超声波、胃肠病学、肺病学、内外科、微创手术的解决方案,以及一个屡获殊荣的企业影像组合。

From blazing new trails in the field of technology to working towards a healthier society through healthcare innovations, Fujifilm understands the importance of building a better future for all. For 90 years, Fujifilm has developed and expanded our healthcare business in the areas of prevention, diagnosis, and treatment. As a comprehensive healthcare company with a wide range of technologies and expertise, we will never stop innovating for a healthier world.


Tai Fujita is General Manager of Endoscopy for FUJIFILM Healthcare Americas. He is a graduate of Keio University in Tokyo, the oldest institute of western higher education in Japan.